PubMed Top Medical Papers2026-07-21Five papers from July 14-21: OPTIMA-AF leads the PubMed windowA five-paper PubMed digest covering AF-PCI antithrombotics, severe HIV-associated pneumonia, blood p-tau217, B-cell lymphoma immunotherapy, and SOD1-ALS gene silencing.
PubMed Top Medical Papers2026-07-14EPCAT III leads July 14 papersThis week’s PubMed top-five digest leads with EPCAT III’s NEJM arthroplasty thromboprophylaxis trial, followed by LatAm-FINGERS, YEARS for cancer-associated PE workups, amyloid PET Centiloid thresholds, and a negative ceperognastat Alzheimer trial.
PubMed Top Medical Papers2026-07-07POLY-HF leads July 7 papersWeekly PubMed top-five digest for the June 30 9:19 a.m. to July 7 9:00 a.m. UTC-5 window. POLY-HF leads, followed by LITESPARK-022, OVERLORD-MS, COMPETE, and HTD1801, with quantitative outcomes, evidence strength, limitations, and clinical implications for each paper.
PubMed Top Medical Papers2026-06-30Acetaminophen leads June 30 papersA shortened-window weekly PubMed digest led by a sibling-matched acetaminophen pregnancy study, plus infigratinib, ReMIND T cells, TBI biomarker caveats, and OPTIMUM low-back-pain results.
PubMed Top Medical Papers2026-06-28HARMONi-6 leads June 28 papersToday’s PubMed digest ranks five high-impact papers from the June 27 09:00 to June 28 09:00 ET window, led by HARMONi-6 in advanced squamous NSCLC, with CHAMP-UK atropine, MajesTEC-5 catch-up, STAR AMD follow-up, and a Korean post-COVID asthma cohort.
PubMed Top Medical Papers2026-06-26Cliramitug leads June 26 papersToday’s PubMed/Nature digest ranks five high-impact clinical and biomedical papers from the June 25 09:23 to June 26 09:00 window: cliramitug ATTR-CM extension, PARP exceptional responders, AAV1-hOTOF re-dosing, DAPHNe 5-year ERBB2-positive breast cancer follow-up, and a GPT-4o clinical decision-support RCT in Kenya.
PubMed Top Medical Papers2026-06-25Four NEJM trials and a plasma immunotherapy signalJune 25: NEJM breaks its 7-day drought with four original trials — CAR T at 10 years, RR-TB 6-month regimen, PFA vs antiarrhythmics for persistent AF, and TXA in major noncardiac surgery — plus a Nature Medicine metabolomics study pinpointing plasma histidine as a cross-tumor ICI response predictor.
PubMed Top Medical Papers2026-06-24Five papers: June 24, 2026Five papers from the June 23–24, 2026 PubMed window: Nature Medicine's Talos platform extracts 241 new diagnoses from 4,735 unresolved rare-disease genomes; The Lancet reports the first MRI-deflatable tracheal balloon for fetal CDH and the world's first combined bladder-kidney transplant; Cell maps the conserved pre-death "disease-associated motor neuron" state in ALS; and Lancet Public Health quantifies an 84% one-year mortality reduction with buprenorphine in 175,191 OAT initiators.
PubMed Top Medical Papers2026-06-23Five papers: June 23, 2026Five papers from the June 22–23, 2026 PubMed window, ranked by journal impact tier: a Cell mechanistic study linking cuproptosis and anti-PD-L1 checkpoint resistance; two JAMA Internal Medicine papers on APOL1 genotype risk in living kidney donors and a VHA multilevel stewardship trial cutting unnecessary antiplatelet-DOAC combinations; a Nature Cancer paper revealing a sex-specific GABA→MDSC suppression axis in glioblastoma; and a Nature Communications phase I KRAS peptide vaccine trial with encouraging immunogenicity in MMRp/MSS colorectal cancer.
PubMed Top Medical Papers2026-06-22Five papers: June 22, 2026Five papers from the June 22, 2026 window — the Nature Medicine drought ends with a large-biobank prospective study (N = 154,169 + 10,262 validation) linking generational increases in biological aging to early-onset cancer risk (HR 1.08 per SD PhenoAge; immune aging → lung HR 1.89), and a News & Views contextualizing Korean nationwide evidence that e-cigarettes after cessation may blunt lung cancer risk reduction. Nature Communications contributes three papers: higher IVF trigger-day hCG dose linked to reduced offspring DNA methylation and suboptimal neurodevelopment in 1,333 singletons, with EHMT1 rescue in mice; AREL1 identified as a cholesterol-regulated MASH fibrosis driver in a specific HSC subpopulation, targeted therapeutically by vitamin A-LNPs; and AOC1/spermidine/EIF5A hypusination as the placental pathway controlling labor timing, with spermidine preventing preterm birth in mice.
PubMed Top Medical Papers2026-06-21Five papers: June 21, 2026Five papers from the June 21, 2026 window — a Sunday weekend drought that left the major journals without new primary research, with Nature Communications filling the gap. Cambridge builds the first human iPSC cerebral organoid modeling MELAS (m.3243A>G), confirming heteroplasmy-dependent loss of deep-layer cortical neurons against autopsy. UMass Chan's multiplexed mRNA nanoparticle cocktail (IL-12/IL-18/CCL5/CXCL10/IFNβ + antigen) achieves 50% curative responses in autochthonous KPC pancreatic cancer mice. Shanghai Children's Medical Center identifies Piezo1→Chemerin→Cmklr1 as the epicardial mechanosensing axis in cardiac pressure overload, with therapeutic benefit from α-NETA. UCL/GOSH's ARC syndrome gene therapy preclinical data show clean safety separation: liver-specific LP1 promoter safe at 9 months, ubiquitous EF1α drives hepatic tumors. Barts/AstraZeneca establish replication origin firing capacity as a cross-cancer ATRi sensitivity biomarker.
PubMed Top Medical Papers2026-06-20Five papers: June 20, 2026Five papers indexed June 20, 2026, ranked by journal IF tier and translational signal. Cell presents a scalable CAR-myeloid progenitor immunotherapy platform; Lancet Healthy Longevity delivers an IPD meta-analysis of 24,510 men showing testosterone below ~8.6 nmol/L associated with 18% higher cancer death risk; Lancet Infectious Diseases quantifies 85% of HTLV-1 infections as sexually transmitted; two Nature Communications papers identify CD95L→OTULIN as a druggable ROS pathway in ANCA vasculitis and show systemic polyamines rescue lethal arrhythmias in Short QT Syndrome type 3.
